Itraconazol Viatris (Itraconazole)

Itraconazole blocks the fungal enzyme lanosterol 14α‑demethylase, preventing the synthesis of ergosterol, an essential component of the fungal cell membrane. This disruption impairs membrane integrity, inhibiting fungal growth and leading to cell death.

The dosage of Itraconazol Viatris is determined by the prescribing clinician based on the specific infection, patient weight, renal and hepatic function, and other clinical factors. No fixed regimen is provided here; the prescriber sets the appropriate dose.

Safety data for itraconazole in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and decisions should be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with fluconazole, another triazole, itraconazole has a broader spectrum against molds such as Aspergillus and offers stronger activity against dimorphic fungi. However, itraconazole has a higher potential for drug‑drug interactions and may require therapeutic drug monitoring, whereas fluconazole is generally better tolerated but less effective against certain systemic infections.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children. Do not expose the medication to extreme heat or humidity.

Itraconazol Viatris is taken orally, usually with food or a full glass of water to improve absorption. The tablet or capsule should be swallowed whole and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious adverse events include hepatotoxicity (liver injury), congestive heart failure due to fluid retention, severe allergic reactions such as anaphylaxis, QT‑interval prolongation leading to cardiac arrhythmias, and rare visual disturbances. Patients should be monitored closely for signs of these conditions.

Itraconazol Viatris is contraindicated in patients with known hypersensitivity to itraconazole or any component of the formulation, and in individuals with a history of severe heart failure. Caution is also advised for patients with significant liver disease, uncontrolled arrhythmias, or those taking contraindicated interacting medications.